| IFB (Institut Français de Bioinformatique) |
|
The IFB is the national bioinformatics infrastructure that provides support, deploys services, organizes training, and carries out innovative developments for the life sciences communities. The IFB brings together 36 bioinformatics platforms affiliated with France’s leading research organizations: 21 member platforms, 7 contributing platforms, and 8 associated teams. Thanks to this nationwide coverage, the IFB fosters a national bioinformatics community by pooling technical and human resources and disseminating expertise. A coordinating platform, IFB-core, located at Genoscope, coordinates the roadmap’s initiatives, manages the pooling of financial resources, and represents the infrastructure at the national and international levels. | (members of the IFB Executive Board and Deputy Director of IFB-core) |
Advanded BioDesignOvercoming cancer drug resistance |
|
Advanced BioDesign is a clinical-stage biotechnology company. Advanced BioDesign is driven by the ambition to treat all patients with chemotherapy-resistant cancers that exhibit high levels of ALDH1. Guillaume Martin, COO | Ismail Ceylan, CEO | Mileidys Perez, CSO
|
(CDI, Advanced BioDesign) |